NASDAQ · Financial Statements

TeraWulf Inc. (WULF) Revenue, Earnings & Financial Statements

$11.67 NASDAQ: WULF Market Cap $5.85B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

TeraWulf Inc. most recently reported annual revenue of $168.0M, a net loss of $661.0M. Revenue grew at an average annual rate of 66.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

TeraWulf Inc.: Revenue rose from $18.0M in 2016 to $168.0M in 2025, a change of +833.3% over 9 years; net profit was positive in 0 of 10 reported years; operating margin moved from -0.1% to -101.1%, a shift of -101.0 percentage points; the most recent year shows a net loss of $661.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$18.0M$17.0M$18.0M$18.0M$13.0M$0$15.0M$69.0M$140.0M$168.0M
Operating Expenses$18.0M$18.0M$18.0M$18.0M$15.0M$43.0M$59.0M$99.0M$216.0M$339.0M
Operating Profit$0$0$0−$1.0M−$1.0M−$43.0M−$44.0M−$29.0M−$76.0M−$170.0M
Operating Margin-0.1%-2.7%1.2%-4.9%-10.6%—-291.0%-42.5%-54.4%-101.1%
Other Income$0$0$0$0$1.0M−$4.0M−$42.0M−$44.0M−$22.0M−$491.0M
Interest$0$0$0$0$2.0M$2.0M$25.0M$35.0M$20.0M$80.0M
Depreciation$1.0M$1.0M$1.0M$1.0M$1.0M$0$7.0M$29.0M$61.0M$93.0M
Profit Before Tax$0−$1.0M$0−$1.0M−$1.0M−$47.0M−$86.0M−$73.0M−$98.0M−$661.0M
Tax rate (%)5.8%56.9%24.8%17.4%32.3%1.3%0.3%0.0%26.4%-0.0%
Net Profit$0$0$0−$1.0M$0−$96.0M−$91.0M−$73.0M−$72.0M−$661.0M
EPS−$0.03−$0.11$0.07−$0.41−$0.22−$1.12−$0.83−$0.35−$0.21−$1.66

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$23.0M$42.0M$36.0M$27.0M$35.0M$34.0M$48.0M$51.0M$36.0M$34.0M$45.0M$76.0M
Operating Expenses$28.0M$45.0M$42.0M$43.0M$86.0M$94.0M$58.0M$64.0M$122.0M$170.0M$185.0M$164.0M
Operating Profit−$5.0M−$2.0M−$7.0M−$16.0M−$51.0M−$60.0M−$10.0M−$14.0M−$87.0M−$136.0M−$140.0M−$88.0M
Operating Margin-20.0%-5.5%-19.0%-58.1%-147.0%-173.3%-21.3%-27.5%-241.8%-401.2%-313.7%-115.7%
Interest$9.0M$11.0M$5.0M$0$3.0M$4.0M$4.0M$10.0M$62.0M$67.0M$56.0M$54.0M
Profit Before Tax−$11.0M−$10.0M−$12.0M−$20.0M−$52.0M−$61.0M−$18.0M−$455.0M−$127.0M−$428.0M−$941.0M$710.0M
Tax rate (%)0.0%0.0%6.6%-13.4%0.0%0.0%0.0%0.0%-0.1%-0.0%0.0%0.0%
Net Profit−$11.0M−$10.0M−$11.0M−$23.0M−$29.0M−$61.0M−$18.0M−$455.0M−$127.0M−$428.0M−$940.0M$710.0M
EPS−$0.04−$0.03−$0.03−$0.06−$0.07−$0.16−$0.05−$1.13−$0.32−$1.01−$1.94−$0.03

Over the 10 years reported for TeraWulf Inc., borrowings increased from $3.0M in 2016 to $5.2B in 2025, cash stood at $3.3B in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.00 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$18.0M$17.0M$17.0M$17.0M$30.0M$265.0M$318.0M$378.0M$788.0M$6.6B
Current Assets$9.0M$8.0M$9.0M$9.0M$6.0M$68.0M$14.0M$63.0M$281.0M$3.5B
Cash$1.0M$1.0M$2.0M$1.0M$6.0M$46.0M$1.0M$54.0M$274.0M$3.3B
Inventory$2.0M$2.0M$2.0M$2.0M$0$0$0$0$0$0
Receivables$2.0M$2.0M$2.0M$2.0M$0$0$0$1.0M$4.0M$5.0M
Fixed Assets$9.0M$8.0M$8.0M$8.0M$22.0M$92.0M$203.0M$216.0M$505.0M$1.7B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$3.0M$3.0M$3.0M$2.0M$104.0M$104.0M$99.0M$99.0M$0$712.0M
Other Assets$0$0$0$0$0$0$0$0$0$55.0M
Total Liabilities$5.0M$4.0M$4.0M$5.0M$2.0M$142.0M$200.0M$156.0M$543.0M$6.4B
Current Liabilities$1.0M$1.0M$1.0M$2.0M$2.0M$46.0M$126.0M$155.0M$52.0M$1.7B
Borrowings$3.0M$3.0M$3.0M$3.0M$96.0M$96.0M$129.0M$124.0M$491.0M$5.2B
Other Liabilities$2.0M$1.0M$1.0M$2.0M$0$46.0M$71.0M$31.0M$52.0M$1.2B
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$13.0M$13.0M$13.0M$12.0M$28.0M$123.0M$118.0M$222.0M$244.0M$140.0M

For TeraWulf Inc., operating cash flow was positive in 3 of 10 reported years; free cash flow in the latest year was negative at $1.2B; free cash flow was positive in 1 of 10 years; financing activities used $62.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$1.0M$0$1.0M$0$0−$24.0M−$34.0M$4.0M−$24.0M−$123.0M
Investing Cash Flow−$7.0M$0−$1.0M$0$2.0M−$310.0M−$167.0M−$153.0M−$359.0M−$2.4B
Financing Cash Flow$0$0$0$0$0$0$8.0M−$11.0M−$200.0M−$62.0M
Net Cash Flow−$1.0M$0$1.0M−$1.0M$3.0M$43.0M−$38.0M$46.0M$220.0M$3.4B
Free Cash Flow−$1.0M$0$1.0M−$1.0M−$1.0M−$133.0M−$107.0M−$71.0M−$292.0M−$1.2B

Valuation & Return Ratios

MetricValue
PEG Ratio0.09
EV / EBITDA-21.86
FCF Yield-43.75%
Quick Ratio0.97
Interest Coverage-3.42
Return 1Y8.05%
Return 3Y1214.58%
Return 5Y-52.98%

TeraWulf Inc. (WULF) financials — frequently asked questions

What is TeraWulf Inc.'s annual revenue?

TeraWulf Inc. (WULF) reported annual revenue of $168.0M in its most recent fiscal year.

What is TeraWulf Inc.'s net profit?

TeraWulf Inc. (WULF) reported a net loss of $661.0M in its most recent fiscal year.

What is WULF EV/EBITDA?

TeraWulf Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -21.86. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Financial - Capital Markets stocks

MS revenue $115.0BGS revenue $125.1BSCHW revenue $27.7BHOOD revenue $4.5BRJF revenue $15.9BTW revenue $2.1BLPLA revenue $17.0BCRCL revenue $2.7BEVR revenue $3.9BSF revenue $6.3BAll Financial - Capital Markets stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
WULF Overview WULF Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.